Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
AG-1478
Cat. No.:
OB0425LY-107
Appearance:
Solid
Purity:
99.22%
Identity:
Confirmed by LC-MS.
Size:
Add to basket
Product Overview
Description:
AG-1478 is a selective epidermal growth factor receptor (EGFR) inhibitor.
Synonyms:
153436-53-4; Tyrphostin AG 1478; N-(3-Chlorophenyl)-6,7-dimethoxyquinazolin-4-amine; 4-(3-Chloroanilino)-6,7-dimethoxyquinazoline; 4-Quinazolinamine, N-(3-chlorophenyl)-6,7-dimethoxy-
CAS No.:
153436-53-4
Compound CID:
2051
Formula:
C16H14ClN3O2
Formula Weight:
315.75
Specification
Target:
EGFR; Influenza virus; HCV
Pathway:
JAK/STAT signaling; Protein tyrosine kinase/RTK; Anti-infection
Solubility:
DMSO
Storage:
Storage at -20°C.
Applications:
AG-1478 can be used to study the EGFR signaling pathway and help explore its role in tumor cell proliferation, migration and survival.
